About our team.

The Global Alzheimer's Platform Foundation (GAP) is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those living with Alzheimer's and Parkinson's — by reducing the time and cost of clinical trials.

0 years

Clinical Trial experience

Combined clinical trial experience across the GAP team.

Multi-disciplinary

Expertise spans Alzheimer's, Parkinson's, epilepsy, mental health, Down Syndrome, TBI and stroke.

Global by design

We coordinate with international research organizations to share information and align initiatives worldwide.

GAP Staff

GAP Staff 49

Board of Directors

Board of Directors 6

01 John Dwyer

02 Michael J. Glosserman

03 Drew Holzapfel

04 George Vradenburg

05 Pascale Witz

06 Neil Buckholtz, PhD In Memoriam

Key Advisors

Key Advisors 17

01 Robert Alexander, MD

02 Mark Brody, MD

03 Samantha Budd Haeberlein, PhD

04 Jeffrey Burns, MD

05 Sharon Cohen, MD

06 Rachelle Doody, MD

07 Howard Fillit, MD

08 Michael Irizarry, MD

09 Lynn Kramer, MD

10 Mike Krautkramer, MBA

11 Simon Lovestone, PhD, MRCPsych

12 Thomas Obisesan, MD

13 Stephen Salloway, MD

14 Allison Searle, BSc

15 Pierre Tariot, MD

16 Luc Truyen, MD, PhD

17 Serge Van Der Geyten, PhD

Our Partners

The Global Alzheimer's Platform Foundation is grateful to be supported by the following philanthropic and industry partners.

Philanthropic Partners

Alzheimer's Drug Discovery Foundation® (ADDF)

Gates Ventures

The Dolby Fund

Vradenburg Foundation

2026 Conference Sponsors · Gold Level

AbbVie

Biogen

IXICO

Eli Lilly & Company

Industry Partners

Janssen

Eli Lilly & Company

Biogen

Roche

Eisai